Sab Biotherapeutics Stock Price History
| SABSW Stock | USD 0.03 0 14.34% |
If you're considering investing in SAB Stock, it is important to understand the factors that can impact its price. As of today, the current price of SAB Biotherapeutics stands at 0.03, as last reported on the 21st of March, with the highest price reaching 0.03 and the lowest price hitting 0.03 during the day. SAB Biotherapeutics is out of control given 3 months investment horizon. SAB Biotherapeutics retains Efficiency (Sharpe Ratio) of 0.0449, which indicates the company had a 0.0449 % return per unit of risk over the last 3 months. We are able to interpolate and collect thirty different technical indicators, which can help you to evaluate if expected returns of 1.11% are justified by taking the suggested risk. Use SAB Biotherapeutics Standard Deviation of 31.34, semi deviation of 18.39, and Market Risk Adjusted Performance of 14.63 to evaluate company specific risk that cannot be diversified away.
At this time, SAB Biotherapeutics' Common Stock Shares Outstanding is fairly stable compared to the past year. Other Stockholder Equity is likely to climb to about 177.9 M in 2025, whereas Liabilities And Stockholders Equity is likely to drop slightly above 63.5 M in 2025. . At this time, SAB Biotherapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to climb to 0.63 in 2025, whereas Price Earnings Ratio is likely to drop (0.85) in 2025. SAB Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
SAB |
Sharpe Ratio = 0.0449
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SABSW | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 24.73 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.11 actual daily | 22 78% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average SAB Biotherapeutics is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SAB Biotherapeutics by adding it to a well-diversified portfolio.
Book Value 3.998 | Shares Float 6.7 M | Shares Short Prior Month 2.8 K | Earnings Share 0.292 | Shares Short 1.2 K |
SAB Biotherapeutics Stock Price History Chart
There are several ways to analyze SAB Stock price data. The simplest method is using a basic SAB candlestick price chart, which shows SAB Biotherapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 16, 2025 | 0.15 |
| Lowest Price | March 18, 2025 | 0.0251 |
SAB Biotherapeutics March 21, 2025 Stock Price Synopsis
Various analyses of SAB Biotherapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell SAB Stock. It can be used to describe the percentage change in the price of SAB Biotherapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of SAB Stock.| SAB Biotherapeutics Price Rate Of Daily Change | 1.14 | |
| SAB Biotherapeutics Price Daily Balance Of Power | 1.00 |
SAB Biotherapeutics March 21, 2025 Stock Price Analysis
SAB Stock Price History Data
The price series of SAB Biotherapeutics for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 0.12 with a coefficient of variation of 57.2. The price distribution for the period has arithmetic mean of 0.06. The median price for the last 90 days is 0.05.| Open | High | Low | Close | Volume | ||
03/21/2025 | 0.03 | 0.03 | 0.03 | 0.03 | ||
| 03/19/2025 | 0.03 | 0.03 | 0.03 | 0.03 | 4,915 | |
| 03/18/2025 | 0.03 | 0.03 | 0.03 | 0.03 | 80.00 | |
| 03/14/2025 | 0.03 | 0.03 | 0.03 | 0.03 | 275.00 | |
| 03/12/2025 | 0.03 | 0.03 | 0.03 | 0.03 | 10.00 | |
| 03/11/2025 | 0.03 | 0.03 | 0.03 | 0.03 | 10.00 | |
| 03/10/2025 | 0.03 | 0.03 | 0.03 | 0.03 | 12,800 | |
| 03/07/2025 | 0.03 | 0.03 | 0.03 | 0.03 | 1.00 | |
| 03/06/2025 | 0.03 | 0.03 | 0.03 | 0.03 | 253.00 | |
| 03/05/2025 | 0.03 | 0.03 | 0.03 | 0.03 | 1,400 | |
| 03/04/2025 | 0.03 | 0.03 | 0.03 | 0.03 | 3,719 | |
| 02/28/2025 | 0.03 | 0.03 | 0.03 | 0.03 | 1,352 | |
| 02/27/2025 | 0.03 | 0.04 | 0.03 | 0.03 | 5,751 | |
| 02/26/2025 | 0.03 | 0.03 | 0.03 | 0.03 | 10,464 | |
| 02/25/2025 | 0.03 | 0.04 | 0.03 | 0.03 | 3,609 | |
| 02/24/2025 | 0.03 | 0.04 | 0.03 | 0.04 | 1,500 | |
| 02/21/2025 | 0.03 | 0.03 | 0.03 | 0.03 | 6,225 | |
| 02/20/2025 | 0.03 | 0.03 | 0.03 | 0.03 | 529.00 | |
| 02/19/2025 | 0.04 | 0.04 | 0.03 | 0.03 | 3,838 | |
| 02/18/2025 | 0.04 | 0.04 | 0.03 | 0.03 | 5,975 | |
| 02/14/2025 | 0.04 | 0.04 | 0.04 | 0.04 | 2,498 | |
| 02/13/2025 | 0.03 | 0.04 | 0.03 | 0.04 | 10,101 | |
| 02/12/2025 | 0.04 | 0.04 | 0.03 | 0.03 | 21,612 | |
| 02/11/2025 | 0.03 | 0.03 | 0.03 | 0.03 | 5,872 | |
| 02/10/2025 | 0.04 | 0.04 | 0.03 | 0.03 | 12,362 | |
| 02/06/2025 | 0.04 | 0.04 | 0.04 | 0.04 | 1,419 | |
| 02/05/2025 | 0.03 | 0.05 | 0.03 | 0.04 | 7,366 | |
| 02/04/2025 | 0.04 | 0.04 | 0.04 | 0.04 | 36,931 | |
| 02/03/2025 | 0.04 | 0.04 | 0.04 | 0.04 | 121,888 | |
| 01/31/2025 | 0.04 | 0.04 | 0.03 | 0.04 | 107,214 | |
| 01/30/2025 | 0.03 | 0.04 | 0.03 | 0.03 | 29,578 | |
| 01/29/2025 | 0.04 | 0.04 | 0.03 | 0.04 | 62,158 | |
| 01/28/2025 | 0.05 | 0.06 | 0.03 | 0.04 | 567,088 | |
| 01/27/2025 | 0.10 | 0.11 | 0.08 | 0.11 | 48,008 | |
| 01/24/2025 | 0.08 | 0.11 | 0.06 | 0.11 | 307,847 | |
| 01/23/2025 | 0.09 | 0.11 | 0.09 | 0.11 | 6,901 | |
| 01/22/2025 | 0.12 | 0.14 | 0.12 | 0.12 | 2,356 | |
| 01/21/2025 | 0.11 | 0.15 | 0.10 | 0.15 | 8,127 | |
| 01/17/2025 | 0.12 | 0.12 | 0.09 | 0.11 | 2,080 | |
| 01/16/2025 | 0.15 | 0.15 | 0.15 | 0.15 | 202.00 | |
| 01/15/2025 | 0.08 | 0.08 | 0.08 | 0.08 | 1,520 | |
| 01/14/2025 | 0.13 | 0.13 | 0.08 | 0.08 | 7,329 | |
| 01/13/2025 | 0.14 | 0.14 | 0.12 | 0.13 | 1,178 | |
| 01/10/2025 | 0.11 | 0.11 | 0.11 | 0.11 | 1,030 | |
| 01/08/2025 | 0.12 | 0.15 | 0.10 | 0.13 | 39,102 | |
| 01/07/2025 | 0.08 | 0.12 | 0.08 | 0.10 | 25,261 | |
| 01/06/2025 | 0.10 | 0.12 | 0.08 | 0.09 | 48,083 | |
| 01/03/2025 | 0.06 | 0.06 | 0.06 | 0.06 | 6,026 | |
| 01/02/2025 | 0.06 | 0.06 | 0.06 | 0.06 | 1,253 | |
| 12/31/2024 | 0.08 | 0.08 | 0.07 | 0.08 | 23,813 | |
| 12/30/2024 | 0.08 | 0.08 | 0.05 | 0.08 | 16,484 | |
| 12/27/2024 | 0.09 | 0.10 | 0.08 | 0.08 | 2,851 | |
| 12/26/2024 | 0.07 | 0.11 | 0.06 | 0.09 | 75,467 | |
| 12/24/2024 | 0.08 | 0.09 | 0.05 | 0.05 | 49,606 | |
| 12/23/2024 | 0.09 | 0.09 | 0.06 | 0.08 | 24,172 | |
| 12/20/2024 | 0.09 | 0.09 | 0.08 | 0.09 | 11,642 | |
| 12/19/2024 | 0.05 | 0.11 | 0.04 | 0.10 | 106,163 | |
| 12/18/2024 | 0.06 | 0.06 | 0.04 | 0.04 | 25,646 | |
| 12/17/2024 | 0.06 | 0.08 | 0.06 | 0.07 | 36,606 | |
| 12/16/2024 | 0.05 | 0.05 | 0.05 | 0.05 | 1,215 | |
| 12/13/2024 | 0.05 | 0.05 | 0.05 | 0.05 | 3,709 |
About SAB Biotherapeutics Stock history
SAB Biotherapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for SAB is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in SAB Biotherapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing SAB Biotherapeutics stock prices may prove useful in developing a viable investing in SAB Biotherapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 5 M | 9.4 M |
SAB Biotherapeutics Stock Technical Analysis
SAB Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
| All Next | Launch Module |
SAB Biotherapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for SAB Biotherapeutics' price direction in advance. Along with the technical and fundamental analysis of SAB Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of SAB to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0956 | |||
| Jensen Alpha | 3.04 | |||
| Total Risk Alpha | 5.67 | |||
| Sortino Ratio | 0.1333 | |||
| Treynor Ratio | 14.62 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for SAB Stock Analysis
When running SAB Biotherapeutics' price analysis, check to measure SAB Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SAB Biotherapeutics is operating at the current time. Most of SAB Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of SAB Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SAB Biotherapeutics' price. Additionally, you may evaluate how the addition of SAB Biotherapeutics to your portfolios can decrease your overall portfolio volatility.